James Kelly Ganjei Inmune Bio, Inc. (INMB) insider trading activity

INMB Quotes by TradingView

James Kelly Ganjei is Director of Inmune Bio, Inc.. Currently has a direct ownership of 17,793 shares of INMB, which is worth approximately $156,934. The most recent transaction as insider was on Mar 22, 2022, when has been sold 17,793 shares (Common Stock) at a price of $8.43 per share, resulting in proceeds of $149,995. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.8K
0% 3M change
0% 12M change
Total Value Held $156,934

James Kelly Ganjei Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2022
BUY
Grant, award, or other acquisition
$149,995 $8.43 p/Share
17,793 Added 50.0%
17,793 Common Stock
JKG

James Kelly Ganjei

Director
La Jolla, CA

Track Institutional and Insider Activities on INMB

Follow Inmune Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INMB shares.

Notify only if

Insider Trading

Get notified when an Inmune Bio, Inc. insider buys or sells INMB shares.

Notify only if

News

Receive news related to Inmune Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INMB